1 terminated. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Terminated 1 |
Follow Akcea Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Characterize Adverse Events Occurring Within One Day of TEGSEDI Administration to Adult Participants With hATTR-PN TEGSEDI - Hereditary Transthyretin Amyloidosis With Polyneuropthy | Phase 4 | Terminated | Akcea Therapeutics | 8 | 2021-01-21 | 2025-04-10 |
Amyloidosis (1) · Amyloidosis, Hereditary, Transthyretin-Related (1)
Inotersen (1)
Canada (1) · United States (1)